Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: A correlative MILD trial study

Journal of Clinical Oncology

Volumn 32, Issue 8, 2014, Pages 768-773

  Sozzi, Gabriella ^a   Boeri, Mattia ^a   Rossi, Marta ^d   Verri, Carla ^a   Suatoni, Paola ^a   Bravi, Francesca ^d,e   Roz, Luca ^a   Conte, Davide ^a   Grassi, Michela ^a   Sverzellati, Nicola ^f   Marchiano, Alfonso ^c   Negri, Eva ^d   La Vecchia, Carlo ^d,e   Pastorino, Ugo ^b  

^a Istituto Nazionale dei Tumori   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c Istituto Nazionale dei Tumori   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLASSIFIER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LOW DOSE COMPUTED TOMOGRAPHY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICRORNA SIGNATURE CLASSIFIER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SMOKING; VALIDATION STUDY; AGED; BLOOD; CHI SQUARE DISTRIBUTION; GENE EXPRESSION PROFILING; GENETIC SCREENING; GENETICS; ITALY; KAPLAN MEIER METHOD; LABORATORY DIAGNOSIS; LUNG TUMOR; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY (TOPIC); PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; RISK FACTOR; TIME;

AGED; CHI-SQUARE DISTRIBUTION; FALSE POSITIVE REACTIONS; FEMALE; GENE EXPRESSION PROFILING; GENETIC TESTING; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MASS SCREENING; MICRORNAS; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SMOKING; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 84897015133     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.50.4357     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61:69-90, 2011
2. Infante M, Cavuto S, Lutman FR, et al: A randomized study of lung cancer screening with spiral computed tomography: Three-year results from the DANTE trial. Am J Respir Crit Care Med 180:445-453, 2009
3. Saghir Z, Dirksen A, Ashraf H, et al: CT screening for lung cancer brings forward early disease: The randomised Danish Lung Cancer Screening Trial - Status after five annual screening rounds with low-dose CT. Thorax 67:296-301, 2012
4. Pastorino U, Rossi M, Rosato V, et al: Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21:308-315, 2012
5. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al: Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409, 2011
6. Bach PB: Reduced lung-cancer mortality with CT screening. N Engl J Med 365:2036, 2011
7. Goulart BH, Bensink ME, Mummy DG, et al: Lung cancer screening with low-dose computed tomography: Costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw 10:267-275, 2012
8. Iorio MV, Croce CM: MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics - A comprehensive review. EMBO Mol Med 4:143-159, 2012
9. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513-10518, 2008
10. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997-1006, 2008
11. Boeri M, Verri C, Conte D, et al: MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108:3713-3718, 2011
12. Kirschner MB, Kao SC, Edelman JJ, et al: Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6:e24145, 2011
13. Pritchard CC, Kroh E, Wood B, et al: Blood cell origin of circulating microRNAs: A cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5:492-497, 2012
14. Heagerty PJ, Lumley T, Pepe MS: Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337-344, 2000 (Pubitemid 30422619)
15. Zheng Y, Heagerty PJ: Prospective accuracy for longitudinal markers. Biometrics 63:332-341, 2007
16. Parmar MK, Machin D: Survival Analysis: A Practical Approach. Chichester, United Kingdom, John Wiley and Sons, 1995
17. Bach PB, Mirkin JN, Oliver TK, et al: Benefits and harms of CT screening for lung cancer: A systematic review. JAMA 307:2418-2429, 2012
18. Peres J: Lung cancer screening gets risk-specific. J Natl Cancer Inst 105:1-2, 2013
19. Boeri M, Pastorino U, Sozzi G: Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Cancer J 18:268-274, 2012
20. Lam S, Boyle P, Healey GF, et al: EarlyCDT-Lung: An immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 4:1126-1134, 2011
21. Bianchi F, Nicassio F, Marzi M, et al: A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 3:495-503, 2011
22. Gallo A, Tandon M, Alevizos I, et al: The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7:e30679, 2012
23. Arroyo JD, Chevillet JR, Kroh EM, et al: Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108:5003-5008, 2011
24. Turchinovich A, Weiz L, Langheinz A, et al: Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223-7233, 2011
25. Yang M, Chen J, Su F, et al: Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 10:117, 2011